13-30461330-GAAA-GAAAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_002128.7(HMGB1):c.*26dupT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.20 ( 3496 hom., cov: 17)
Exomes 𝑓: 0.22 ( 8133 hom. )
Failed GnomAD Quality Control
Consequence
HMGB1
NM_002128.7 3_prime_UTR
NM_002128.7 3_prime_UTR
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0750
Publications
6 publications found
Genes affected
HMGB1 (HGNC:4983): (high mobility group box 1) This gene encodes a protein that belongs to the High Mobility Group-box superfamily. The encoded non-histone, nuclear DNA-binding protein regulates transcription, and is involved in organization of DNA. This protein plays a role in several cellular processes, including inflammation, cell differentiation and tumor cell migration. Multiple pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2015]
HMGB1 Gene-Disease associations (from GenCC):
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.26 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002128.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HMGB1 | NM_002128.7 | MANE Select | c.*26dupT | 3_prime_UTR | Exon 5 of 5 | NP_002119.1 | |||
| HMGB1 | NM_001313892.2 | c.*26dupT | 3_prime_UTR | Exon 5 of 5 | NP_001300821.1 | ||||
| HMGB1 | NM_001313893.1 | c.*26dupT | 3_prime_UTR | Exon 5 of 5 | NP_001300822.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HMGB1 | ENST00000341423.10 | TSL:1 MANE Select | c.*26dupT | 3_prime_UTR | Exon 5 of 5 | ENSP00000345347.5 | |||
| HMGB1 | ENST00000399489.5 | TSL:1 | c.*247dupT | 3_prime_UTR | Exon 5 of 5 | ENSP00000382412.1 | |||
| HMGB1 | ENST00000339872.8 | TSL:2 | c.*26dupT | 3_prime_UTR | Exon 5 of 5 | ENSP00000343040.4 |
Frequencies
GnomAD3 genomes AF: 0.202 AC: 29513AN: 146150Hom.: 3491 Cov.: 17 show subpopulations
GnomAD3 genomes
AF:
AC:
29513
AN:
146150
Hom.:
Cov.:
17
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.263 AC: 37162AN: 141356 AF XY: 0.263 show subpopulations
GnomAD2 exomes
AF:
AC:
37162
AN:
141356
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.217 AC: 267177AN: 1229630Hom.: 8133 Cov.: 32 AF XY: 0.216 AC XY: 130900AN XY: 605748 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
267177
AN:
1229630
Hom.:
Cov.:
32
AF XY:
AC XY:
130900
AN XY:
605748
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1739
AN:
27042
American (AMR)
AF:
AC:
4550
AN:
26844
Ashkenazi Jewish (ASJ)
AF:
AC:
3340
AN:
18144
East Asian (EAS)
AF:
AC:
6276
AN:
32852
South Asian (SAS)
AF:
AC:
9647
AN:
61462
European-Finnish (FIN)
AF:
AC:
14210
AN:
44378
Middle Eastern (MID)
AF:
AC:
468
AN:
3240
European-Non Finnish (NFE)
AF:
AC:
216063
AN:
965606
Other (OTH)
AF:
AC:
10884
AN:
50062
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.384
Heterozygous variant carriers
0
11567
23135
34702
46270
57837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
7836
15672
23508
31344
39180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.202 AC: 29518AN: 146236Hom.: 3496 Cov.: 17 AF XY: 0.202 AC XY: 14360AN XY: 71182 show subpopulations
GnomAD4 genome
AF:
AC:
29518
AN:
146236
Hom.:
Cov.:
17
AF XY:
AC XY:
14360
AN XY:
71182
show subpopulations
African (AFR)
AF:
AC:
2998
AN:
38508
American (AMR)
AF:
AC:
2511
AN:
14900
Ashkenazi Jewish (ASJ)
AF:
AC:
612
AN:
3430
East Asian (EAS)
AF:
AC:
1089
AN:
5108
South Asian (SAS)
AF:
AC:
687
AN:
4714
European-Finnish (FIN)
AF:
AC:
3372
AN:
9378
Middle Eastern (MID)
AF:
AC:
36
AN:
292
European-Non Finnish (NFE)
AF:
AC:
17605
AN:
66988
Other (OTH)
AF:
AC:
375
AN:
2018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1021
2041
3062
4082
5103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.